Ischemic stroke risk in patients with dopamine agonist‐treated hyperprolactinemia

Documenti analoghi

• The research trend of hyperprolactinemia from 2011 to 2023 was analyzed by bibliometrics
  di: Kaiyan Liu, et al.
  Pubblicazione: (2024)
• Overexpression of the short isoform of the dopamine D2 receptor causes diet‐induced obesity and hyperglycemia in mice
  di: Hanna Gonzalez, et al.
  Pubblicazione: (2025)
• Magnetic resonance imaging features of hypophysitis in patients with cancer treated with immune checkpoint inhibitors
  di: Anna Angelousi, et al.
  Pubblicazione: (2025)
• The influence of the prolactin/vasoinhibin axis on post‐stroke lesion volume, astrogliosis, and survival
  di: Ximena Castillo, et al.
  Pubblicazione: (2024)
• Maternal immune activation with toll‐like receptor 7 agonist during mid‐gestation alters juvenile and adult developmental milestones and behavior
  di: Julietta A. Sheng, et al.
  Pubblicazione: (2024)